Published on August 6, 2018. Chicago, Illinois, August 1, 2018: GNA Biosolutions was named the winner of the American Association of Clinical Chemistry’s (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that... Read more
Published on July 27, 2018. On July 30, 2018, GNA Biosolutions will be one of three finalists in the American Association of Clinical Chemistry’s (AACC) first-ever Disruptive Technology Award. GNA will be presenting data on the company’s proprietary Pulse Controlled Amplification (PCA) technology during a featured session at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.... Read more
Published on November 13, 2017. Groundbreaking nucleic acid detection technology using nanomaterials DUESSELDORF, Germany, November 13 – GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world’s first Laser PCR® platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair... Read more